|
[1]Lok AS, Heathcote EJ, Hoofnagle JH.Management of hepatitis B:2000-summary of a workshop[J].Gastroenterology, 2001, 120 (7) ∶1828-1853.
|
|
[2]于乐成.慢加急性肝衰竭[J].肝脏, 2007, 12 (2) ∶135-137.
|
|
[3]Kamath PS, Kim WR.Advanced Liver Disease Study Group.The Model for End-stage Liver Disease (MELD) [J].Hepatology, 2007, 45 (3) ∶797-805.
|
|
[4]中华医学会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) ∶56-62.
|
|
[5]中华医学会.肝衰竭诊疗指南[J].中华内科杂志, 2006, 45 (12) ∶1053-1056.
|
|
[6]中华医学会.慢性乙型肝炎防治指南[J].中华传染病杂志, 2005, 23 (6) ∶421-431.
|
|
[7]Lindh M, Horal P, Dhillon AP, et al.Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B[J].J Viral Hepat, 2000, 7 (4) ∶258-267.
|
|
[8]Polson J, Lee WM.American association for the study of liver disease.AASLD position paper:the management of acute liver failure[J].Hepatology, 2005, 41 (5) ∶1179-1197.
|